Series B - Oxford Biotrans
Investment Firm
Overview
Oxford Biotrans is a University of Oxford spin-out firm developing enzymatic process technologies that yield high-value chemical compounds.
Announced Date
Oct 10, 2017
Funding Type
Series B
Highlights
Location
Europe
Social
Participant Investors
2
| Investor Name |
|---|
 Touchstone Innovations |
 University of Oxford |
Round Details and Background
Oxford Biotrans raised $2773936 on 2017-10-10 in Series B
Oxford Biotrans is a University of Oxford spin-out firm developing enzymatic process technologies that yield high-value chemical compounds.
Company Funding History
3
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 10, 2017 |  Series B - Oxford Biotrans | 4 | - | 2.8M |
| Aug 04, 2015 | Series A - Oxford Biotrans | 1 | - | 3.9M |
| Oct 01, 2013 | Seed Round - Oxford Biotrans | - | 970.3K |
Recent Activity
There is no recent news or activity for this profile.